Introduction {#s1}
============

Intraocular pressure readings are influenced by central corneal thickness (CCT) and may therefore affect diagnosis, screening, and the management of patients with glaucoma and ocular hypertension. There is evidence that IOP may be underestimated in patients with thinner and overestimated in patients with thicker corneas [@pone.0066158-Whitacre1]. A good correlation between IOP measured by Goldmann applanation tonometry and intracamerally-measured IOP was demonstrated in patients with a normal corneal thickness of about 550 µm [@pone.0066158-Boehm1].

Central corneal thickness of ocular hypertensive patients is also presumed to be a powerful predictor of glaucoma development, as eyes with corneal thickness of 555 microns or less showed a greater risk of developing glaucoma than those with a corneal thickness of more than 588 microns [@pone.0066158-Gordon1].

Many factors can affect CCT in the general population, such as age, gender, environmental and genetic factors, and race. The Ocular Hypertension Treatment Study demonstrated a correlation between greater mean central corneal thickness and younger age, female gender, and diabetes. Patients with ocular hypertension had thicker corneas than the general population [@pone.0066158-Brandt1]. In contrast, other studies found a correlation between higher CCT and male gender and older age [@pone.0066158-Vijaya1], [@pone.0066158-Tomidokoro1].

Data on central corneal thickness have already been evaluated in several populations. Comparison among studies is difficult due to different measurement techniques (non-contact vs. contact measurements techniques) and missing weighting procedure in most population studies. Aghaian et al. investigated differences in central corneal thickness of 801 subjects, demonstrating that the CCT of Japanese participants was significantly lower than that of Caucasians, Chinese, Filipinos, and Hispanics, and greater than that of African Americans [@pone.0066158-Aghaian1]. Compared to white subjects, African American subjects have thinner corneas [@pone.0066158-Brandt1].

There are few data available on the normal CCT in Indians. The Chennai Glaucoma Study is a population-based study of adults aged 40 years and older residing in the southern Indian state of Tamil Nadu. As part of a comprehensive eye examination, CCT and IOP measurements were obtained [@pone.0066158-Vijaya1].

European studies that assessed CCT data are the European Glaucoma Prevention Study [@pone.0066158-Pfeiffer1], [@pone.0066158-Miglior1], Reykjavik Eye Study [@pone.0066158-Eysteinsson1] and Rotterdam study [@pone.0066158-Wolfs1].

The purpose of this population-based, cross-sectional study is to evaluate the gender- and age-related distribution of central corneal thickness in a large German sample in the Rhine-Main region, and furthermore, to evaluate the relationship between central corneal thickness, intraocular pressure and other ocular factors.

Materials and Methods {#s2}
=====================

The Gutenberg Health Study {#s2a}
--------------------------

The Gutenberg Health Study is a prospective, population-based cohort study being carried out in the Rhine-Main region of Germany (Rhineland-Palatinate). Its primary aim is to develop a new cardiovascular risk score, which takes into account classic, psychosocial, environmental and lifestyle risk factors, subclinical atherosclerotic disease, protein patterns and genetic variability concerning myocardial infarction and cardiovascular death as primary endpoints. Apoplexy, overall deaths, development of heart failure, and diabetes serve as secondary endpoints.

The population of interest is the population of Rhineland-Palatinate. 15,000 inhabitants in the districts Mainz and Mainz-Bingen aged between 35 and 74 years (equal distribution of subjects in each age group) have been selected as our study population. Two and a half years after baseline examination, participants will be contacted for a follow-up interview. Five years after baseline investigation, the study participants will be invited for a second follow-up, and the entire series of investigations will be repeated.

The structured series of investigations is performed within 5 hours.

Questionnaires on psychosocial work stress, physical activity, active and environmental smoking, nutrition, noise and air pollution will be assessed by a structured, computer-assisted, personal interview. Medical technical parameters include ankle-brachial index, anthropometric measurements, arterial waveform collection, blood pressure and heart rate measurements, sonography of the carotid arteries, echocardiography, electrocardiogram, endothelial function measurement, flow-mediated and nitro-mediated dilation, spirometry, expired carbon-monoxide measurement, laboratory parameters, biobanking and genotyping, as well as laboratory safety and routine parameters (electrolytes, kidney, liver, blood count coagulation, musculature, enzymes, inflammation, diabetes, lipids, homocysteine, thyroid, and oxidative stress).

Ethics Statement {#s2b}
----------------

Written informed consent was obtained from each participant prior to any examination, according to the tenets of the Declaration of Helsinki. The study was approved by the Medical Ethics Committee of Mainz, Rhineland Palatinate, and by the local and federal data safety commissioners of the University Medical Center Mainz.

A sample of 5000 inhabitants within the Gutenberg Health Study (GHS) was included in this survey. 2540 male and 2460 female subjects between 35 and 75 years of age were examined between April 2007 and October 2008. Mean age was 56.0±10.9 (male) and 55.0±11.0 (female) years. Beside the extensive internal/general examination, all participants underwent an ophthalmological examination including visual acuity testing and refraction (Humphrey® Automated refractor/Keratometer (HARK) 599™, slitlamp biomicroscopy (Haag-Streit BM 900^®^, Bern Switzerland), intraocular pressure measurement (with a non-contact tonometer, NT 2000^TM^, Nidek Co./Japan), central corneal thickness and keratometry measurement (non-contact pachymetry with the Pachycam^TM^, Oculus, Wetzlar/Germany), and fundus examination. The measurement of corneal thickness is based on Scheimpflug images of a horizontal 4 mm cut through the corneal apex. With Scheimpflug acquisition, 600 absolute height values are analysed. The slitbeam illuminates the corneal surface to the corneal endothelium. The transparent cells of the cornea scatter the slit, leading to an apparently self-illuminated image of the cutting plane. This image is recorded by a camera angled at 45° whereas the image plane itself is located at 45° to the optical axis of the camera optics. This is required for defined cross-sectional cuts (Scheimpflug image). Participants were asked to fill out a questionnaire about their glaucoma history. Furthermore, all subjects underwent non-mydriatic fundus photography and visual field testing using frequency-doubling technology perimetry (Visucam *^ProNM^* ^,^ ™, and Humphrey Matrix Perimeter, Carl Zeiss Meditec AG, Jena, Germany). To measure intraocular pressure, we used the mean of three measurements within a range of 3 mm Hg for each eye, starting with the right eye. Iris colour was classified in blue, grey, green and brown by the ophthalmologist via an electronic case report file (eCRF). Spherical equivalent was calculated by adding the spherical correction value plus half the cylinder value.

Inclusion and exclusion criteria {#s2c}
--------------------------------

Subjects were randomly drawn from the local registry, Mainz, Germany and the Mainz-Bingen district. The sample was stratified 1∶1 for gender, residency, and age decades. Exclusion criteria were insufficient command of the German language to understand study documents, and computer-assisted interviews without translation, and the physical or psychological incapacity to travel to the study centre and/or to cooperate in the investigations. Participants with relevant corneal pathologies, corneal scarring, corneal dystrophies (such as cornea guttata/Fuchs endothelial dystrophy), and participants wearing hard contact lenses who had undergone laser in situ keratomileusis (LASIK), laser subepithelial keratomileusis (LASEK) or other refractive surgeries affecting the cornea were also excluded. Furthermore, participants with leucoma corneae, anophthalmia, or phthisis bulbi were excluded from the study. Measurements of central corneal thickness had to have a quality index of at least 90% as automatically calculated with each measurement. A quality index of 90% is recommended by the manufacturer\'s manual.

Main Outcome Measures {#s2d}
---------------------

Main outcome measures of this study are the association between central corneal thickness and ocular parameters such as refraction (spherical equivalent), intraocular pressure, contact lens wear, lens status, and iris colour. Furthermore, correlations between CCT and gender, age, reported history of glaucoma and/or existing antiglaucomatous medication are assessed.

Statistical Analysis {#s2e}
--------------------

All data underwent quality control by a central data management unit and were checked for completeness and correctness by predefined algorithms and quality plausibility controls. The sample size was defined by the sample size calculation of the primary endpoint (cardiovascular death). All data was weighted with the old European standard population. Descriptive statistics including means, standard deviation (SD), range and 95% reference range were performed to evaluate the distribution of central corneal thickness in the studied population. Data was stratified by age, gender and eye. Furthermore, linear regression analysis and multivariate regression analysis were performed to assess ophthalmological parameters possibly correlated with central corneal thickness measurements. Possible differences between right and left eyes were analysed using Wilcoxon tests for related samples. SAS (Version 9.2, SAS-Institute Inc., Cary, NC, USA) and SPSS (Version 15, SPSS Inc., Chicago, USA) statistical software packages were used for analysis.

Results {#s3}
=======

Our population sample consisted of 2540 men and 2460 women. Mean age was 56.0±10.9 years (men) and 55.0±11.0 years (women), respectively. Men suffered more often from high blood pressure, diabetes, dyslipidemia, obesity, and showed a greater use of nicotine. Prevalence of eye variables such as glaucoma (defined by a history of glaucoma or by antiglaucomatous medication), contact lens wear, eye drop application, relevant corneal pathologies (status following excimer laser surgery, corneal clouding, corneal scars, and status following penetrating corneal injury), lens status (pseudophakia), and eye diseases in family history is presented in [table 1](#pone-0066158-t001){ref-type="table"}. Glaucoma prevalence was higher in women than men (1.68% versus 1.34%) as defined by the patient or antiglaucomatous treatment. Women were contact lens wearers more often (6.51% versus 3.24%) and used eye drops more frequently than men (12.43% versus 6.79%). They also reported a family history of eye disease more frequently (12.63% versus 7.97%). More men had undergone cataract surgery than the women (1.76% versus 1.52%).

10.1371/journal.pone.0066158.t001

###### Prevalence of selected eye parameters, stratified by gender and weighted with the old European standard population.

![](pone.0066158.t001){#pone-0066158-t001-1}

  Weighted                                   All      Men    Women
  ---------------------------------------- -------- ------- --------
  Glaucoma                                  1.49%    1.34%   1.68%
  Contact lenses                            4.98%    3.24%   6.51%
  Eye drops                                 9.68%    6.79%   12.43%
  Relevant eye drops                        1.72%    1.46%   2.03%
  Corneal pathology                         3.74%    4.59%   2.96%
  Relevant corneal pathology                0.48%    0.48%   0.48%
  Lens status (Pseudophakia)                1.63%    1.53%   1.76%
  Family history of eye disease             10.45%   7.97%   12.63%
  Relevant eye disease in family history    4.61%    3.79%   5.58%

Relative frequencies are shown.

Relevant eye drops: antiglaucomatous eye drops.

Eye drops in general: drops for dry-eye syndrome, general eye care products.

Relevant cornel pathologies: corneal scarring, corneal dystrophies (such as cornea guttata/Fuchs endothelial dystrophy).

Relevant eye disease in family history: history of glaucoma.

Measurements of central corneal thickness were available in 4758 right eyes and 4761 left eyes. Of these, 4708 right eyes and 4721 left eyes achieved the quality criteria (quality index of 90%) and were included in the analysis. Mean CCT was 554.2±34.9 µm in the total study sample (weighted for age and gender: 554.2±34.8 µm). [Table 2](#pone-0066158-t002){ref-type="table"} presents the weighted 5^th^ and 95^th^ percentile of CCT in men and women. Men had slightly thicker central corneal thickness (mean CCT: 500 and 613 µm, 5^th^ and 95^th^ percentile, respectively) than women (mean CCT: 496 and 610 µm, 5^th^ and 95^th^ percentile, respectively) in all age decades. By tendence, men between 35 and 44 years had thicker CCTs than older men (561.1 μm (493.6--628.8 μm) versus 554.1 μm (488.7--619.4 μm), 557.5 μm (488.7--626.3 μm), and 555.5 μm (488.8--622.2 μm)), respectively (see [table 3](#pone-0066158-t003){ref-type="table"}).

10.1371/journal.pone.0066158.t002

###### Distribution of central corneal thickness in the overall study sample in men and women.
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  Weighted                       All                                  Men                                 Women
  -------------- ------------------------------------ ------------------------------------ ------------------------------------
  **CCTR**         495, 609 (5th, 95th percentile)      497, 610 (5th, 95th percentile)      493, 608 (5th, 95th percentile)
  **CCTL**         498, 616 (5th, 95th percentile)      503, 618 (5th, 95th percentile)      496, 616 (5th, 95th percentile)
  **CCTMean**      498, 612 (5th, 95th percentile)      500, 613 (5th, 95th percentile)      496, 610 (5th, 95th percentile)
  **CCTMin**       494, 606 (5th, 95th percentile)      495, 608 (5th, 95th percentile)      492, 606 (5th, 95th percentile)
  **CCTDelta**    1.00, 22.00 (5th, 95th percentile)   1.00, 23.00 (5th, 95th percentile)   1.00, 22.00 (5th, 95th percentile)

Values are weighted with the old European standard population between 35 and 74 years.

10.1371/journal.pone.0066158.t003

###### Distribution of central corneal thickness in the sample population stratified by age and gender, after weighting procedure.
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                Age decades                                                                                   
  ------- ----------------------- ------------------------- ----------------------- ------------------------- -------------------------
  Men      558.7 (490.8--626.7)     552.3 (485.8--618.7)     555.6 (486.4--624.9)     553.7 (486.1--621.3)      555.2 (487.3--623.2)
  Women    548.7 (481.1--616.4)     549.8 (479.7 (619.8)     549.2 (479. 9--618.4)    550.8 (478.8--622.8)      549.5 (480.0--618.9)
  Total    **553 (484.1−621.6)**   **551.2 (483.3−619.2)**   **552.5 (482.9−622)**   **552.3 (482.4−622.3)**   **552.2 (483.3−621.1)**

  CCTL (N = 4721)    *95% reference range (Mean −1.96\*SD, Mean +1.96\*SD) is shown*                                                                              
  ----------------- ----------------------------------------------------------------- ----------------------- ------------------------- ------------------------- -------------------------
  Men                                     563.3 (493.3--633.3)                         556.0 (490.1--621.9)     559.5 (489.8--629.2)      557.2 (489.4 −625.1)      559.3 (490.7--627.9)
  Women                                   553.6 (483.2--624.1)                         553.6 (483.9--622.8)     553.0 (483.4--622.7)      555.2 (483.3--627.0)      553.6 (483.2--624.1)
  Total                                  **557.5 (486.7−628.1)**                       **550 (486.7−623.3)**   **556.4 (486.4−626.3)**   **556.3 (486.3−626.2)**   **556.2 (486.5−625.9)**

  CCTMean (N = 4698)    *95% reference range (Mean −1.96\*SD, Mean +1.96\*SD) is shown*                                                                                   
  -------------------- ----------------------------------------------------------------- -------------------------- -------------------------- -------------------------- -------------------------
  Men                                        561.1 (493.6--628.8)                           554.1 (488.7--619.4)       557.5 (488.7--626.3)       555.5 (488.8--622.2)       557.3 (490--624.5)
  Women                                      551.0 (483.8--618.2)                           551.8 (481.9--621.7)       551.1 (482.7--619.5)       552.9 (481.7--624.2)      551.6 (482.6--620.5)
  Total                                    **555.2 (486.8--623.5)**                       **553.1 (485.8--620.4)**   **554.4 (485.5--623.3)**   **554.3 (485.2--623.4)**   **554.2 (485.9−622.5)**

  CCTMin (N = 4698)    *95% reference range (Mean −1.96\*SD, Mean +1.96\*SD) is shown*                                                                                    
  ------------------- ----------------------------------------------------------------- -------------------------- -------------------------- --------------------------- --------------------------
  Men                                       556.7 (489.1--624.4)                           550.0 (484.1--615.8)       553.4 (485.5--621.3)       550.7 (484.5--617.0)        552.9 (485.8--620.1)
  Women                                     546.8 (479.4--614.3)                           547.6 (477.9--617.4)       546.6 (478.4--614.9)       548.5 (476.8--620.2)        547.3 (487.3--616.3)
  Total                                   **550.9 (482.4--619.4)**                       **549.0 (481.6--616.4)**   **550.1 (481.7--618.5)**   **549.7 (480.6--618.8.)**   **549.9 (481.7--618.2)**

  CCT Δ (N = 4698)    *Median and Quartile intervals are shown (skewed distribution)*                                            
  ------------------ ----------------------------------------------------------------- ------------- ------------- ------------- -------------
  Men                                                8                                       7             7             8             7
                                                  (3--12)                                 (3--11)       (3--12)       (3--14)       (3--12)
  Women                                              7                                       7             7             7             7
                                                  (3--11)                                 (3--12)       (3--12)       (4--12)       (3--12)
  Total                                              7                                       7             7             7             7
                                                **(3--12)**                             **(3--11)**   **(3--12)**   **(3--12)**   **(3--12)**

CCTR: Mean central corneal thickness of all right eyes.

CCTL: Mean central corneal thickness of all left eyes.

CCTMean: Mean central corneal thickness between right and left eyes (only analysed when both measurements were available).

CCTMin: The smaller central corneal thickness value between right and left eyes (only analysed when both measurements were available).

CCT **Δ**: Difference in micrometer between CCT of the right versus left eye (only analysed when both measurements were available).

[Table 3](#pone-0066158-t003){ref-type="table"} furthermore, presents the distribution of CCT in men and women stratified by age and gender including the 95% reference range. Smallest CCT of mean CCT ranged from 481.7 µm (at age 65--74) to 483.8 µm (at age 35--44), with women again having thinner CCTs than men. The range of thick mean CCT in the population was between 619 and 628 µm in men and between 618.2 and 624.2 µm in women. A difference in mean CCT was found between right and left eyes in the total study population. The difference in CCT between both eyes (CCT total) was 7 micrometers (median) with quartile intervals of 3 to 13 µm (skewed distribution), depending on the age decade. However, Wilcoxon test for related samples revealed a significant correlation between both eyes (p = 0.0001).

Intraocular pressure was correlated with CCT. This relationship is shown in [figures 1](#pone-0066158-g001){ref-type="fig"} and [2](#pone-0066158-g002){ref-type="fig"}. In male right eyes, a 10 µm increase in CCT was correlated with an IOP increase of 0.37 mm Hg, r^2^ = 0.205 (female right eyes: 0.35 mm Hg change in IOP with a 10 µm CCT increase, r^2^ = 0.235). In the left eyes of all the men, a 10 µm increase in CCT correlated with an IOP increase of 0.38 mm Hg, r^2^ = 0.209 (women: 0.45 mm Hg change in IOP with a 10 µm CCT increase, r^2^ = 0.229). The correlation between different ophthalmological parameters and central corneal thickness was analysed by multivariate regression; results are in [table 4a and 4b](#pone-0066158-t004){ref-type="table"}. Gender was correlated with central corneal thickness (regression coefficient −4.963 for right eyes and −4.735 for left eyes, p\<0.0001), meaning that mean CCT in men was 4.963 μm (right eye) and 4.735 μm (left eye) thicker than in women.

![Scatter plots and univariable linear regression of the difference between non-contact applanation tonometry readings versus central corneal thickness in µm in right eyes.](pone.0066158.g001){#pone-0066158-g001}

![Scatter plots and univariable linear regression of the difference between non-contact applanation tonometry readings versus central corneal thickness in µm in left eyes.](pone.0066158.g002){#pone-0066158-g002}

10.1371/journal.pone.0066158.t004

###### Results of multivariate regression analysis (adjusted for gender and age) evaluating the correlation between ophthalmological parameters and central corneal thickness measurements analysed in right and left eyes separately.
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  Right Eyes                                                                    
  ------------------------------------------------------- ------------ -------- --------------
  **Parameter**                                            **0.0061**           
  Gender                                                                −4.963   **\<0.0001**
  Age in years                                                          −0.060      0.2417
  Spherical equivalent (right eye)                                      0.473     **0.0303**
  Glaucoma[\*](#nt112){ref-type="table-fn"}, no vs. yes                 3.664       0.2571
  Contact lenses, no vs. yes                                            0.100       0.9717
  Lens status (right eye), phakic vs. pseudophakic                      0.373       0.8960
  Iris colour (right eye), light vs. dark                               0.675       0.5476

  Left Eyes                                                                    
  ------------------------------------------------------- ----------- -------- --------------
  **Parameter**                                            **0.006**           
  Gender                                                               −4.735   **\<0.0001**
  Age in years                                                         −0.070      0.1688
  Spherical equivalent (right eye)                                     0.370       0.0885
  Glaucoma[\*](#nt112){ref-type="table-fn"}, no vs. yes                3.572       0.2752
  Contact lenses, no vs. yes                                           −2.864      0.3089
  Lens status (right eye), phakic vs. pseudophakic                     2.146       0.4719
  Iris colour (right eye), light vs. dark                              1.066       0.3501

Definition of glaucoma: as disclosed by the participant and/or by the use of antiglaucomatous medication.

Neither age, contact lens wear, positive family history for glaucoma, lens status, nor iris colour showed a correlation with CCT. For right eyes, refraction was positively correlated with CCT, as shown in [table 4a](#pone-0066158-t004){ref-type="table"} (regression coefficient 0.473, p = 0.0303).

Glaucoma defined on the basis of disclosure by the participant and/or antiglaucomatous medication showed no correlation with CCT, as presented in [table 5](#pone-0066158-t005){ref-type="table"}.

10.1371/journal.pone.0066158.t005

###### Correlation between central corneal thickness and existence of glaucoma as disclosed by the participant and/or use of antiglaucomatous medication, stratified by gender.
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  Glaucoma                                          
  --------------- ---------------- ---------------- ----------
  **CCTR** (µm)                                     
  Men                555.3±34.6       551.9±36.5       0.51
  Women              549.4±35.4       553.4±38.4       0.38
  Total            **558.2±39.6**   **553.4±37.5**   **0.71**
  **CCTL** (µm)                                     
  Men                559.3±35.0       555.4±34.4       0.42
  Women              553.5±35.9       558.2±39.6       0.32
  Total            **556.2±35.5**   **557.6±37.3**   **0.68**

Discussion {#s4}
==========

Central corneal thickness plays a major role in the diagnosis of glaucoma [@pone.0066158-Gordon1], [@pone.0066158-Pfeiffer1], [@pone.0066158-Miglior1], [@pone.0066158-Nangia1]--[@pone.0066158-Leskea1]. It was the purpose of this study to evaluate central corneal thickness in a large population, since there are to date no population-based data on CCT in a German population. Mean CCT in the study population was 554.2±34.8 µm. That men have thicker CCT than women has been reported in other population-based studies as well [@pone.0066158-Vijaya1], [@pone.0066158-Pfeiffer1], [@pone.0066158-Nangia1]. One has to bear in mind that all comparisons among studies regarding mean CCT are dependent from the standard population used. We used the old European population. The mean CCT value in a German population is considerably higher than that in the Japanese Tajimi study (521±32 µm) [@pone.0066158-Tomidokoro1], Central India Eye and Medical Study (514±33 µm) [@pone.0066158-Nangia1], Barbados Eye Study (530 µm, no standard deviation given) [@pone.0066158-Nemesure1], Icelandic Reykjavik Eye Study (529±39 µm) [@pone.0066158-Eysteinsson1], Chennai Glaucoma study (520.7±33.4 μm) [@pone.0066158-Vijaya1] and in indigenous Australians (508±33 µm) [@pone.0066158-Landers1]. Similar or slightly higher CCT values than in our study were found in the Beijing Eye Study (556.2±33.1 µm) [@pone.0066158-Zhang1], Rotterdam Eye Study (537 µm) [@pone.0066158-Wolfs1], European Glaucoma Prevention Study (572.6±37.4 µm) [@pone.0066158-Pfeiffer1], and the Ocular Hypertensive Treatment Study (578.1±36.8 µm) for those not developing glaucoma, 551.2±36.0 µm for those developing glaucoma [@pone.0066158-Gordon1], [@pone.0066158-Gordon2], and the Tehran Eye Study (555.6±39.9 µm) [@pone.0066158-Hashemi1].

We noted an age dependency in mean CCT: 35-44-year-old participants had thicker CCT than participants aged 45--54. No further decrease in mean CCT was found in participants 45 years and older, and multivariate regression analysis revealed no correlation between CCT and age ([Tables 5a and 5b](#pone-0066158-t005){ref-type="table"}). In contrast, a population-based study in 3280 Malayan subjects aged 40--80 years [@pone.0066158-Wong1] revealed a continuous decrease in mean CCT over all age decades (40--49 years: 548.3 µm, 50--59 years: 544 µm, 60--69 years: 540.8 µm, 70--79 years: 533 µm). An age-related decrease in mean CCT has been shown in various clinical and population-based studies [@pone.0066158-Nangia1], [@pone.0066158-Kawase1], [@pone.0066158-Rochtchina1].

Previous population-based studies such as the Central India Eye and Medical Study [@pone.0066158-Nangia1] or Tehran Eye Study [@pone.0066158-Hashemi1] found refraction not to be significantly correlated with central corneal thickness. The GHS Eye Survey found refraction to be positively correlated with CCT in right eyes in multivariate regression analysis after adjusting for gender and age.

Intraocular pressure was positively correlated with central corneal thickness. This was expected, since we used non-contact tonometry in this study, which is known to be positively correlated with CCT in the literature [@pone.0066158-Kotecha1]--[@pone.0066158-Siganos1]. In general, there is good agreement between clinic-based and population-based studies reporting an increase in measured IOP as CCT increases. We observed results similar to those of Siganos [@pone.0066158-Siganos1] and Tonnu [@pone.0066158-Tonnu1], whereas the Reykjavik Eye Study [@pone.0066158-Eysteinsson1] reported a slightly flatter slope estimate compared to our results (women: 0.28 mm Hg an men: 0.22 mm Hg per 10 µm increase in CCT, respectively). There is evidence that non-contact tonometry is more susceptible than Goldmann applanation tonometry to CCT effects [@pone.0066158-Tonnu1]. This may be due to the IOP measuring technique. In non-contact tonometry, the cornea is deformed over a shorter period (resulting in greater corneal stiffness) compared to Goldmann applanation tonometry, where measurement is relatively static [@pone.0066158-Tonnu1], [@pone.0066158-Hjortdal1]. However, the study protocol required non-contact methods for the ophthalmological examinations to make them contrivable for ophthalmological technical assistants, too. New tonometry technologies have been developed recently, such as dynamic contour tonometry (DCT) and the ocular response analyzer (ORA), both being less dependent on CCT. The ORA (Reichert Inc., Depew, NY, USA), measures two applanation events, one as the pressure in the air jet rises and one as it falls. It thus measures corneal biomechanical properties such as corneal hysteresis and corneal elasticity. The reported effects of CCT on IOP measurements by DCT and ORA have been inconsistent among studies [@pone.0066158-Realini1]--[@pone.0066158-Medeiros1]. Some found IOP independent from CCT [@pone.0066158-Siganos1], [@pone.0066158-Kaufmann1]--[@pone.0066158-Hager1], whereas a population-based cross-sectional study found DCT measurements slightly affected by CCT [@pone.0066158-Francis1]. However, IOP measurements are affected by corneal thickness and other biomechanical properties, and CCT measurements will remain a key clinical factor when assessing an ophthalmological patient.

CCT measurements are important when monitoring glaucoma patients and ocular hypertensives, since studies have shown that thin CCT is associated with an increased glaucoma risk [@pone.0066158-Gordon1], [@pone.0066158-Miglior1], [@pone.0066158-Miglior3]. Furthermore, CCT measurements are helpful before and after kerato-refractive surgery and can assist in detecting endothelial disease and graft failure after penetrating keratoplasty [@pone.0066158-Grewal1].

Several instruments are available to measure corneal thickness with varying degrees of accuracy. Ultrasound pachymetry is commonly used to measure CCT (the "gold standard") because it is easy to use and relatively inexpensive. Disadvantages of ultrasound pachymetry include the need to anaesthetise the cornea, cornea--probe contact, corneal indentation and the possible compression effect during measurement and corneal surface disturbance. There is also the risk of corneal epithelial damage and the transmission of infection. The reproducibility of ultrasound pachymetry measurements depends largely on examiner experience [@pone.0066158-Grewal1]. In our study, we used a non-contact pachymeter based on the Scheimpflug principle. Previous studies showed that Scheimpflug CCT measurements are more reproducible and repeatable than those obtained with US pachymetry, suggesting that the Scheimpflug camera is suitable for disease staging and follow-up. Furthermore, there is evidence that ultrasound pachymetry measurements are systematically thicker than Scheimpflug CCT measurements [@pone.0066158-Grewal1], [@pone.0066158-Barkana1]. In our study we used Scheimpflug imaging for CCT measurements, probably leading to less thicker CCTs than those obtained via ultrasound pachymetry techniques.

Based on a reported history of glaucoma and/or therapy with antiglaucomatous medication, prevalence for glaucoma in our cohort was 1.49% ([Table 2](#pone-0066158-t002){ref-type="table"}). This is in line with results from other population-based studies such as the Beaver Dam Eye Study (overall prevalence of 2.1%, ranging from 0.9% in 43--54 year olds to 4.7% in people older than 75 years) [@pone.0066158-Klein1], the Blue Mountains Eye Study (overall glaucoma prevalence in residents over 49 years of 3.0%, of whom 49% were diagnosed previously) [@pone.0066158-Mitchell1], a meta-analysis of recent population-based studies, summarising prevalence estimates for glaucoma in the United States (overall prevalence of 1.89% in people 40 years and older) [@pone.0066158-Friedman1], the Egna-Neumarkt Study (overall prevalence of glaucoma: 1.4% in subjects older than 40 years) [@pone.0066158-Bonomi1], in the Melbourne Visual Impairment Project (overall prevalence of 1.7% in the population, increasing steadily with age from 0.1% at ages 40 to 49 years to 9.7% in subjects aged 80 to 89 years) [@pone.0066158-Wensor1], and the Rotterdam Eye Study (overall prevalence of glaucoma of 0.8% ranging from 0.1% to 1.2% -depending on the definition for glaucoma in subjects older than 55 years) [@pone.0066158-Wolfs2]. Higher prevalence of glaucoma has been detected in Japanese eyes [@pone.0066158-Iwase1], in Latinos of Mexican ancestry [@pone.0066158-Varma1], and in populations of African origin [@pone.0066158-Tielsch1]--[@pone.0066158-Friedman2] The varying results in prevalence data among the different population-based studies is related in part to the particular population, inclusion criteria, and the glaucoma definition. Although our cohort\'s prevalence data concurs with the glaucoma prevalence reported in the literature, one must bear in mind that -- at least in this evaluation -- glaucoma was not determined from optic nerve head data and/or visual field data. It however, had no impact on the results of this study. Data including glaucoma diagnosis by structure (optic nerve head) and function (FDT matrix) will be presented in future publications and are under preparation. Furthermore, results are strongly depending from the standard population used for comparison.

The strength of our study is that it is population-based and includes a high number of participants. Standardised and broad ophthalmological examination strengthens the validity of these results. The use of non-contact techniques is easy and feasible and of common use in population based studies. On the other side, this might be a limitation of this study, too. Although often used in (population-based) studies, non-contact tonometry has not been considered the goldstandard for IOP measurement. However, the protocol required a minimum of 3 measurements to decrease variability and the use of this technique had no impact on the purpose of the study.

In conclusion, the Gutenberg Health Study presents for the first time population-based CCT values in a representative German population of 5,000 middle-aged inhabitants. By weighting all data, results are reliable and applicable to the old European standard population. CCT was positively correlated with IOP and thus confirms results from other population-based surveys. Gender (men had thicker corneas) and spherical equivalent were correlated with CCT as well.

This presentation received the "Best Paper Award 2011" at the DOG meeting in Berlin, 2011.
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